Clinical trial
Trifecta Research Study - An Observational Study Evaluating the Impact of Ibogaine-Magnesium, 5-MeO-DMT, Magnetic e-Resonance Therapy, and Physiological Supplementation in Special Operations Forces Combat Veterans
NCT07717866 is registered in ClinicalTrials.gov with Axial Therapeutic Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Trifecta Research Study - An Observational Study Evaluating the Impact of Ibogaine-Magnesium, 5-MeO-DMT, Magnetic e-Resonance Therapy, and Physiological Supplementation in Special Operations Forces Combat Veterans
- Lead sponsor
- Axial Therapeutic Research
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- August 1, 2022
- Completion date
- November 30, 2026
- Enrollment
- 52 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brain injury, cognitive dysfunction, depression - major depressive disorder, ptsd - post traumatic stress disorder, suicidal ideation